UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

Cephalalgia, 2008-04, Vol.28 (4), p.383-391

2008

Link zum Volltext

Verfügbarkeit prüfen

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Neurología (Barcelona, English ed. ), 2022-06, Vol.37 (5), p.390-402

2022

Link zum Volltext

Verfügbarkeit prüfen

Document of revision and updating of medication overuse headache (MOH)

Neurología (Barcelona, English ed. ), 2021-04, Vol.36 (3), p.229-240

2021

Link zum Volltext

Verfügbarkeit prüfen

Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

Neurología (Barcelona, English ed. ), 2022-06, Vol.37 (5), p.390-402

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Link zum Volltext

Verfügbarkeit prüfen

Document of revision and updating of medication overuse headache (MOH)

Neurología (Barcelona, English ed. ), 2021-04, Vol.36 (3), p.229-240

2021

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the "Act When Mild" Study

International journal of neuroscience, 2011-12, Vol.121 (12), p.655-661

2011

Link zum Volltext

Verfügbarkeit prüfen

One-year prevalence of migraine in Spain: A nationwide population-based survey

Cephalalgia, 2011-03, Vol.31 (4), p.463-470

2011

Link zum Volltext

Verfügbarkeit prüfen

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

Neurología (Barcelona, English ed. ), 2023-04

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology’s Headache Study Group

Neurología (Barcelona, English ed. ), 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

PND99 The Humanistic Disease Burden of Episodic and Chronic Migraine in France, Spain and the United Kingdom

Value in health, 2020-12, Vol.23, p.S640-S641

2020

Link zum Volltext

Verfügbarkeit prüfen

Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients

Neurología (Barcelona, Spain), 2006-05, Vol.21 (4), p.188-191

2006

Link zum Volltext

Verfügbarkeit prüfen

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

Revista de neurologiá, 2024-01, Vol.78 (2), p.47-57

2024

Link zum Volltext

Verfügbarkeit prüfen

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress

Revista de neurologiá, 2021-06, Vol.72, p.S1-S19

2021

Link zum Volltext

Verfügbarkeit prüfen

Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)

Revista de neurologiá, 2013-02, Vol.56 (3), p.143-151

2013

Link zum Volltext

Verfügbarkeit prüfen

Neurocutaneous melanosis

Revista de neurologiá, 1998-05, Vol.26 (153), p.769-771

1998

Link zum Volltext

Verfügbarkeit prüfen

Caracterización del manejo del paciente con migraña en Atención Primaria en España. Análisis de los resultados del proyecto europeo My-LIFE anamnesis

Neurología (Barcelona, Spain), 2023-06, Vol.38, p.S22-S30

2023

Link zum Volltext

Verfügbarkeit prüfen

Headache and wine. Are all wines the same?

Journal of headache and pain, 2013-02, Vol.14 (Suppl 1), p.P32-P32, Article P32

2013

Link zum Volltext

Verfügbarkeit prüfen

Headache and wine. Are all wines the same?

Journal of headache and pain, 2013-02, Vol.1 Suppl 1, p.P32-P32

2013

Link zum Volltext

Verfügbarkeit prüfen

Headache and wine. Are all wines the same?: Doc 371

Journal of headache and pain, 2013-02, Vol.14, p.1

2013

Link zum Volltext

Verfügbarkeit prüfen

CGRP en migraña: de la fisiopatología a la terapéutica

Neurología (Barcelona, Spain), 2022-06, Vol.37 (5), p.390-402

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Link zum Volltext

Verfügbarkeit prüfen

Documento de revisión y actualización de la cefalea por uso excesivo de medicación (CUEM)

Neurología (Barcelona, Spain), 2021-04, Vol.36 (3), p.229-240

2021

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic intracranial hypertension associated with inferior vena cava thrombosis and protein S deficiency

Revista de neurologiá, 2002-02, Vol.34 (4), p.398

2002

Link zum Volltext

Verfügbarkeit prüfen

Familial amyloid polyneuropathy: two new cases of late onset, with many asymptomatic carriers in the family

Revista de neurologiá, 2001-09, Vol.33 (5), p.494-495

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Spanisch
(24)
Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment

Document of revision and updating of medication overuse headache (MOH)

Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

Document of revision and updating of medication overuse headache (MOH)

The Impact of Allodynia on the Efficacy of Almotriptan When Given Early in Migraine: Data From the "Act When Mild" Study

One-year prevalence of migraine in Spain: A nationwide population-based survey

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology’s Headache Study Group

PND99 The Humanistic Disease Burden of Episodic and Chronic Migraine in France, Spain and the United Kingdom

Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress

Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)

Neurocutaneous melanosis

Caracterización del manejo del paciente con migraña en Atención Primaria en España. Análisis de los resultados del proyecto europeo My-LIFE anamnesis

Headache and wine. Are all wines the same?

Headache and wine. Are all wines the same?

Headache and wine. Are all wines the same?: Doc 371

CGRP en migraña: de la fisiopatología a la terapéutica

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study

Documento de revisión y actualización de la cefalea por uso excesivo de medicación (CUEM)

Idiopathic intracranial hypertension associated with inferior vena cava thrombosis and protein S deficiency

Familial amyloid polyneuropathy: two new cases of late onset, with many asymptomatic carriers in the family

Suchergebnisse filtern